1-5 of 5
Thomas Schwaab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-038: Hide and Seq: Radiation-induced immunogenicity of patient tumors revealed by single cell analysis

Free
Jacky L. Chow, Nicholas Hoffend, Madeline Gaudieri, Scott Abrams, Thomas Schwaab, Anurag Singh, Jason Muhitch
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-038.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-038
Published: 15 April 2021
View articletitled, Abstract PO-038: Hide and Seq: Radiation-induced immunogenicity of patient tumors revealed by single cell analysis
Journal Articles

Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

Free
Jay Amin, Bo Xu, Shervin Badkhshan, Terrance T. Creighton, Daniel Abbotoy, Christine Murekeyisoni, Kristopher M. Attwood, Thomas Schwaab, Craig Hendler, Michael Petroziello, Charles L. Roche, Eric C. Kauffman
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (16): 3898–3907.
https://doi.org/10.1158/1078-0432.CCR-18-0252
Published: 14 August 2018
View articletitled, Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
Open the PDF for Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Free
Anurag K. Singh, Timothy B. Winslow, Mohammad Habiby Kermany, Vincent Goritz, Lilia Heit, Austin Miller, Nicholas C. Hoffend, Leighton C. Stein, Lalith K. Kumaraswamy, Graham W. Warren, Wiam Bshara, Kunle Odunsi, Junko Matsuzaki, Scott I. Abrams, Thomas Schwaab, Jason B. Muhitch
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5055–5065.
https://doi.org/10.1158/1078-0432.CCR-16-2946
Published: 31 August 2017
View articletitled, A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Open the PDF for A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Reply

Free
Marc S. Ernstoff, Jan Fisher, John D. Seigne, Zbigniew M. Szczepiorkowski, Nancy A. Crosby, Alan R. Schned, Robert D. Harris, Richard J. Barth, Jr., John A. Heaney, Thomas Schwaab, Adrian Schwarzer, Benita Wolf, Randolph J. Noelle
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7448.
https://doi.org/10.1158/1078-0432.CCR-09-2550
Published: 30 November 2009
View articletitled, Reply
Open the PDF for Reply in another window
Journal Articles

Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients

Free
Thomas Schwaab, Adrian Schwarzer, Benita Wolf, Todd S. Crocenzi, John D. Seigne, Nancy A. Crosby, Bernard F. Cole, Jan L. Fisher, Jill C. Uhlenhake, Diane Mellinger, Cathy Foster, Zbigniew M. Szczepiorkowski, Susan M. Webber, Alan R. Schned, Robert D. Harris, Richard J. Barth, Jr., John A. Heaney, Randolph J. Noelle, Marc S. Ernstoff
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (15): 4986–4992.
https://doi.org/10.1158/1078-0432.CCR-08-3240
Published: 29 July 2009
View articletitled, Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients
Open the PDF for Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients in another window